A recent investment case has shown that a successful polio transition in the WHO Eastern Mediterranean Region can generate a high return on investment.
According to the study, sustaining and integrating polio assets into expanded immunization, surveillance, and emergency response programs can bring economic and social benefits worth an estimated $289.2 billion.
With the current cost of this work being $7.5 billion, it means that for every dollar spent, the return on investment is almost $39.
Novel Polio Vaccine Investments Offer Measurable Returns
Flu Shot Protection Wanes 9% Monthly
It's important to remember that influenza vaccine protection starts very strong but declines throughout flu season as antibody levels wane.
A study published in Eurosurveillance on February 22, 2024, compiled data across nine flu seasons in Ontario, Canada, revealing that influenza vaccine effectiveness (VE) waned about 9% every 28 days beginning 41 days post-vaccination.
This trend was detected in adults but not in children.
Flu Shot Protection Wanes 9% Monthly
It's important to remember that influenza vaccine protection starts very strong but declines throughout flu season as antibody levels wane.
A study published in Eurosurveillance on February 22, 2024, compiled data across nine flu seasons in Ontario, Canada, revealing that influenza vaccine effectiveness (VE) waned about 9% every 28 days beginning 41 days post-vaccination.
This trend was detected in adults but not in children.